- Home
- SLI vs DCTH Comparison
SLI vs DCTH Comparison
Compare SLI & DCTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SLI
- DCTH
- Stock Information
- Founded
- SLI 1998
- DCTH 1988
- Country
- SLI Canada
- DCTH United States
- Employees
- SLI N/A
- DCTH N/A
- Industry
- SLI Major Chemicals
- DCTH Medical/Dental Instruments
- Sector
- SLI Industrials
- DCTH Health Care
- Exchange
- SLI Nasdaq
- DCTH Nasdaq
- Market Cap
- SLI 406.1M
- DCTH 398.2M
- IPO Year
- SLI N/A
- DCTH N/A
- Fundamental
- Price
- SLI $1.66
- DCTH $14.31
- Analyst Decision
- SLI Strong Buy
- DCTH Strong Buy
- Analyst Count
- SLI 2
- DCTH 4
- Target Price
- SLI $3.95
- DCTH $22.25
- AVG Volume (30 Days)
- SLI 1.4M
- DCTH 411.6K
- Earning Date
- SLI 02-06-2025
- DCTH 11-08-2024
- Dividend Yield
- SLI N/A
- DCTH N/A
- EPS Growth
- SLI N/A
- DCTH N/A
- EPS
- SLI 0.61
- DCTH N/A
- Revenue
- SLI N/A
- DCTH $22,644,000.00
- Revenue This Year
- SLI N/A
- DCTH $1,605.13
- Revenue Next Year
- SLI N/A
- DCTH $111.67
- P/E Ratio
- SLI $2.74
- DCTH N/A
- Revenue Growth
- SLI N/A
- DCTH 945.91
- 52 Week Low
- SLI $1.05
- DCTH $3.70
- 52 Week High
- SLI $2.64
- DCTH $14.47
- Technical
- Relative Strength Index (RSI)
- SLI 53.86
- DCTH 70.27
- Support Level
- SLI $1.46
- DCTH $12.14
- Resistance Level
- SLI $1.76
- DCTH $12.98
- Average True Range (ATR)
- SLI 0.11
- DCTH 0.77
- MACD
- SLI 0.02
- DCTH 0.16
- Stochastic Oscillator
- SLI 71.01
- DCTH 95.12
About SLI Standard Lithium Ltd.
Standard Lithium Corp is engaged in the exploration and development of lithium brine properties in the United States. The company is focused on the exploration and development of the Arkansas Lithium Project, which is located in south-central Arkansas. Its other projects comprise the Lanxess Project, Tetra Project, and Bristol Dry Lake Project.
About DCTH Delcath Systems Inc.
Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects.